Dual roles of NRF2 in tumor prevention and progression: possible implications in cancer treatment por Moon, EJ, Giaccia, A

Bringing H2AX into the angiogenesis family. por Rankin, E, Giaccia, A, Hammond, E

Oxygen sensing and the DNA-damage response. por Hammond, E, Kaufmann, MR, Giaccia, A

ATM activation and signaling under hypoxic conditions. por Bencokova, Z, Kaufmann, MR, Pires, I, Lecane, P, Giaccia, A, Hammond, E

Using oxygen dose histograms to quantify voxelised ultra-high dose rate (FLASH) effects in multiple radiation modalities por Van den Heuvel, F, Vella, A, Fiorini, F, Brooke, MD, Hill, MA, Ryan, A, Maughan, T, Giaccia, A

Hypoxia-mediated regulation of DDX5 through decreased chromatin accessibility and post-translational targeting restricts R-loop accumulation por Leszczynka, K, Dzwigonska, M, Estephan, H, Moehlenbrink, J, Bowler, E, Giaccia, A, Mieczkowski, J, Kaminska, B, Hammond, E

Hypoxia inhibits MHC I expression and antigen presentation to escape immune surveillance por Estephan, H, Tailor, A, Parker, R, Kreamer, M, Papandreou, I, Campo, L, Easton, A, Moon, EJ, Denko, N, Ternette, N, Hammond, E, Giaccia, A

Pre-metastatic niches: organ-specific homes for metastases por Peinado, H, Zhang, H, Matei, I, Costa-Silva, B, Hoshino, A, Rodrigues, G, Psaila, B, Kaplan, R, Bromberg, J, Kang, Y, Bissell, M, Cox, T, Giaccia, A, Erler, J, Hiratsuka, S, Ghajar, C, Lyden, D

Neutralization of BAFF and APRIL with engineered soluble BCMA decoy receptor for the treatment of B-cell malignancies por Zhang, XE

Otros Autores: “…Giaccia, A…”

Engineering receptor-based decoys for the treatment of cancer using a yeast surface display platform por Wang, Y

Otros Autores: “…Giaccia, A…”